| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.074 | 79.393 | 88.369 | 56.839 | 76.215 | 83.415 | 115.327 | 141.470 | 145.833 | 140.369 |
| Total Income - EUR | 61.542 | 79.538 | 88.369 | 89.219 | 76.182 | 103.582 | 125.941 | 166.418 | 172.887 | 230.432 |
| Total Expenses - EUR | 39.901 | 33.955 | 56.630 | 68.949 | 58.023 | 65.405 | 68.212 | 102.842 | 107.071 | 104.285 |
| Gross Profit/Loss - EUR | 21.640 | 45.583 | 31.739 | 20.271 | 18.160 | 38.177 | 57.729 | 63.576 | 65.816 | 126.147 |
| Net Profit/Loss - EUR | 19.794 | 44.788 | 30.189 | 19.379 | 17.398 | 37.214 | 56.714 | 61.995 | 64.122 | 119.373 |
| Employees | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Delycontactiv Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.187 | 22.946 | 26.921 | 24.976 | 63.456 | 69.100 | 156.613 | 127.472 | 93.634 | 54.646 |
| Current Assets | 12.940 | 36.687 | 23.290 | 9.044 | 3.208 | 17.072 | 9.343 | 18.835 | 10.572 | 6.719 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.256 |
| Receivables | 0 | 275 | 133 | 266 | 1.685 | 2.180 | 1.448 | 2.102 | 1.908 | 4.461 |
| Cash | 12.940 | 36.412 | 23.157 | 8.778 | 1.523 | 14.893 | 7.895 | 16.733 | 8.664 | 2 |
| Shareholders Funds | 19.839 | 44.841 | 34.867 | 19.430 | 35.731 | 72.267 | 127.379 | 111.155 | 79.748 | 23.077 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.288 | 14.791 | 15.343 | 14.590 | 30.933 | 14.100 | 38.578 | 35.151 | 24.459 | 38.310 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Delycontactiv Medical Srl